Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro

被引:163
作者
d'Amore, F. [1 ]
Gaulard, P. [2 ]
Truemper, L. [3 ]
Corradini, P. [4 ]
Kim, W. -S. [5 ]
Specht, L. [6 ]
Pedersen, M. Bjerregaard [1 ]
Ladetto, M. [7 ]
机构
[1] Aarhus Univ Hosp, Dept Hematol, DK-8000 Aarhus, Denmark
[2] Hop Henri Mondor, Dept Pathol, F-94010 Creteil, France
[3] Univ Gottingen, Dept Hematol & Oncol, D-37073 Gottingen, Germany
[4] Univ Milan, Fdn IRCCS Ist Nazl Tumori, Dept Hematol, Milan, Italy
[5] Samsung Med Ctr, Dept Med, Div Hematoloncol, Seoul, South Korea
[6] Univ Copenhagen, Rigshosp, Dept Hematol & Oncol, DK-2100 Copenhagen, Denmark
[7] Azienda Osped Santi Antonio & Biagio & Cesare Ari, Div Ematol, Alessandria, Italy
关键词
NON-HODGKIN-LYMPHOMA; HIGH-DOSE THERAPY; POSITRON-EMISSION-TOMOGRAPHY; NASAL-TYPE; RADIATION-THERAPY; PHASE-II; ALLOGENEIC TRANSPLANTATION; ONCOLOGY GROUP; WORKING PARTY; RADIOTHERAPY;
D O I
10.1093/annonc/mdv201
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:V108 / V115
页数:8
相关论文
共 63 条
[1]   Clinicopathologic and prognostic significance of cytotoxic molecule expression in nodal peripheral T-cell lymphoma, unspecified [J].
Asano, N ;
Suzuki, R ;
Kagami, Y ;
Ishida, F ;
Kitamura, K ;
Fukutani, H ;
Morishima, Y ;
Takeuchi, K ;
Nakamura, S .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (10) :1284-1293
[2]   High-Dose and Extended-Field Intensity Modulated Radiation Therapy for Early-Stage NK/T-Cell Lymphoma of Waldeyer's Ring: Dosimetric Analysis and Clinical Outcome [J].
Bi, Xi-Wen ;
Li, Ye-Xiong ;
Fang, Hui ;
Jin, Jing ;
Wang, Wei-Hu ;
Wang, Shu-Lian ;
Liu, Yue-Ping ;
Song, Yong-Wen ;
Ren, Hua ;
Dai, Jian-Rong .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (05) :1086-1093
[3]   Metabolic Activity Measured by F-18 FDG PET in Natural Killer-Cell Lymphoma Compared to Aggressive B- and T-Cell Lymphomas [J].
Chan, Winnie K. S. ;
Au, Wing-Yan ;
Wong, Ching-Yee O. ;
Liang, Raymond ;
Leung, Anskar Y. H. ;
Kwong, Yok-Lam ;
Khong, Pek-Lan .
CLINICAL NUCLEAR MEDICINE, 2010, 35 (08) :571-575
[4]   Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome [J].
Corradini, P. ;
Dodero, A. ;
Farina, L. ;
Fanin, R. ;
Patriarca, F. ;
Miceli, R. ;
Matteucci, P. ;
Bregni, M. ;
Scime, R. ;
Narni, F. ;
Pogliani, E. ;
Locasciulli, A. ;
Milani, R. ;
Carniti, C. ;
Bacigalupo, A. ;
Rambaldi, A. ;
Bonifazi, F. ;
Olivieri, A. ;
Gianni, A. M. ;
Tarella, C. .
LEUKEMIA, 2007, 21 (11) :2316-2323
[5]   Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma [J].
Corradini, P. ;
Vitolo, U. ;
Rambaldi, A. ;
Miceli, R. ;
Patriarca, F. ;
Gallamini, A. ;
Olivieri, A. ;
Benedetti, F. ;
Todeschini, G. ;
Rossi, G. ;
Salvi, F. ;
Bruno, B. ;
Baldini, L. ;
Ferreri, A. ;
Patti, C. ;
Tarella, C. ;
Pileri, S. ;
Dodero, A. .
LEUKEMIA, 2014, 28 (09) :1885-1891
[6]   Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells [J].
Corradini, P ;
Dodero, A ;
Zallio, F ;
Caracciolo, D ;
Casini, M ;
Bregni, M ;
Narni, F ;
Patriarca, F ;
Boccadoro, M ;
Benedetti, F ;
Rambaldi, A ;
Gianni, AM ;
Tarella, C .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2172-2176
[7]   Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01 [J].
d'Amore, Francesco ;
Relander, Thomas ;
Lauritzsen, Grete F. ;
Jantunen, Esa ;
Hagberg, Hans ;
Anderson, Harald ;
Holte, Harald ;
Osterborg, Anders ;
Merup, Mats ;
Brown, Peter ;
Kuittinen, Outi ;
Erlanson, Martin ;
Ostenstad, Bjorn ;
Fagerli, Unn-Merete ;
Gadeberg, Ole V. ;
Sundstrom, Christer ;
Delabie, Jan ;
Ralfkiaer, Elisabeth ;
Vornanen, Martine ;
Toldbod, Helle E. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (25) :3093-3099
[8]   Results From a Prospective, Open-Label, Phase II Trial of Bendamustine in Refractory or Relapsed T-Cell Lymphomas: The BENTLY Trial [J].
Damaj, Gandhi ;
Gressin, Remy ;
Bouabdallah, Krimo ;
Cartron, Guillaume ;
Choufi, Bachra ;
Gyan, Emmanuel ;
Banos, Anne ;
Jaccard, Arnaud ;
Park, Sophie ;
Tournilhac, Olivier ;
Schiano-de Collela, Jean-Marc ;
Voillat, Laurent ;
Joly, Bertrand ;
Le Gouill, Steven ;
Saad, Alain ;
Cony-Makhoul, Pascale ;
Vilque, Jean-Pierre ;
Sanhes, Laurence ;
Schmidt-Tanguy, Aline ;
Bubenheim, Michael ;
Houot, Roch ;
Diouf, Momar ;
Marolleau, Jean-Pierre ;
Bene, Marie-Christine ;
Martin, Antoine ;
Lamy, Thierry .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (01) :104-110
[9]   The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells [J].
de Leval, Laurence ;
Rickman, David S. ;
Thielen, Caroline ;
de Reynies, Aurelien ;
Huang, Yen-Lin ;
Delsol, Georges ;
Lamant, Laurence ;
Leroy, Karen ;
Briere, Josette ;
Molina, Thierry ;
Berger, Francoise ;
Gisselbrecht, Christian ;
Xerri, Luc ;
Gaulard, Philippe .
BLOOD, 2007, 109 (11) :4952-4963
[10]   Pathology and biology of peripheral T-cell lymphomas [J].
de Leval, Laurence ;
Gaulard, Philippe .
HISTOPATHOLOGY, 2011, 58 (01) :49-68